Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$335K Sell
4,734
-3,878
-45% -$290K 0.09% 165
2025
Q4
$680K Buy
8,612
+8,596
+53,725% +$680K 0.17% 131
2025
Q3
$1K Buy
+16
New +$1.26K ﹤0.01% 246
2025
Q1
Sell
-963
Closed -$79K 302
2024
Q4
$79K Buy
963
+9
+0.9% +$749 0.02% 246
2024
Q3
$79K Sell
954
-714
-43% -$53.3K 0.01% 280
2024
Q2
$117K Sell
1,668
-1,359
-45% -$97K 0.02% 225
2024
Q1
$224K Buy
3,027
+497
+20% +$34.6K 0.02% 220
2023
Q4
$167K Sell
2,530
-24
-0.9% -$1.5K 0.01% 239
2023
Q3
$161K Sell
2,554
-1,212
-32% -$75.5K 0.01% 250
2023
Q2
$213K Hold
3,766
0.02% 220
2023
Q1
$218K Buy
3,766
+582
+18% +$39.3K 0.01% 206
2022
Q4
$230K Hold
3,184
0.02% 193
2022
Q3
$194K Hold
3,184
0.01% 216
2022
Q2
$200K Buy
3,184
+2,458
+339% +$163K 0.01% 242
2022
Q1
$51K Buy
+726
New +$49.1K ﹤0.01% 389

Other funds holding MET

TOBAM's MET Position: Q1 2026 in Review

TOBAM reduced its MetLife (MET) stake by 45% in Q1 2026, selling an estimated $290K and leaving 4,734 shares worth $335K. The position accounts for 0.09% of the portfolio, ranked #165.

TOBAM first reported a position in MET in Q1 2022 and has held it in 15 quarters since. The position peaked at $680K in Q4 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • TOBAM held 4,734 shares of MetLife worth $335K as of Q1 2026.
  • TOBAM sold 3,878 MetLife shares in Q1 2026, an estimated $290K.
  • MetLife made up 0.09% of TOBAM's portfolio in Q1 2026, its #165 holding.
  • TOBAM first reported a position in MetLife in Q1 2022 and has held it in 15 quarters since.
  • TOBAM's MetLife position peaked at $680K in Q4 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on TOBAM's 13F filing for Q1 2026, filed 12 May 2026.